Anest. intenziv. Med. 2010;21(3):141-145

N-terminal pro-Brain natriuretic peptide (NT-proBNP) in acute brain disease: Elevated serum levels without sodium imbalanceIntensive Care Medicine - Original Paper

Špatenková Věra1,*, Kazda Antonín2, Suchomel Petr1
1 Neurocentrum, Krajská nemocnice, Liberec
2 Ústavu klinické biochemie a laboratorní diagnostiky Všeobecné fakultní nemocnice a 1. lékařské fakulty Univerzity Karlovy, Praha

Objective:
B-type natriuretic peptide is a member of the peptide family which increases urine and sodium output in the kidneys and causes vasodilatation in the vessels. In acute brain disease it is connected with hyponatraemia and natriuresis, forming the cerebral salt wasting syndrome (CSWS). The aim of this study was to evaluate serum NT-proBNP and its relationship to sodium and water metabolism parameters in patients with acute brain disease in the absence of CSWS.

Design:
Retrospective study.
Setting:
Neurological-neurosurgical intensive care unit, Regional Hospital.
Material and method:
We observed NT-proBNP values in 18 patients (9 women, 9 men, mean Glasgow Coma Scale 14 ± 1) with acute brain disease (subarachnoid haemorrhage 9, intracerebral haemorrhage 2, tumour 5, other 2) with normal renal parameters and New York Heart Association (NYHA) classification I. Serum sodium concentration and osmolality were measured on the day of taking the NT-proBNP sample (day 1) and 24 hours later (day 2), further parameters - urine output, urinary loss of sodium, fluid and sodium intake, were observed for a period of 24 hours after the NT-proBNP measurement.

Results:
Serum levels of NT- proBNP (mean 37.4 ± 29.5 pmol/l, 316.8 ± 250.3 pg/ml) were statistically significantly higher than the normal value (14.8 pmol/l, 125 pg/ml, p = 0.005), while no significant changes were observed in the levels between day 1 and 2 of either serum sodium (p = 0.799) or serum osmolality (p = 0.388). Furthermore, there was no proven significant correlation between NT-proBNP and the measured parameters.

Conclusion:
This study showed a significant elevation of NT-proBNP in patients with acute brain disease that was not accompanied by the development of CSWS.

Keywords: B-type natriuretic peptide; NT-proBNP; hyponatraemia; cerebral salt wasting syndrome

Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Špatenková V, Kazda A, Suchomel P. N-terminal pro-Brain natriuretic peptide (NT-proBNP) in acute brain disease: Elevated serum levels without sodium imbalance. Anest. intenziv. Med. 2010;21(3):141-145.
Download citation

References

  1. Ruskoaho, H. et al. Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II. J. Mol. Med., 1997, 75, p. 876-885. Go to original source... Go to PubMed...
  2. Hall, C. Essential biochemistry and physiology of (NT-pro)BNP. Eur. J. Heart Fail, 2004, 6, p. 257-260. Go to original source... Go to PubMed...
  3. Vanderheyden, M. et al. Brain and other natriuretic peptides: molecular aspects. Eur. J. Heart Fail., 2004, 6, p. 261-268. Go to original source... Go to PubMed...
  4. de Bold, A. J. et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci., 1981, 28, p. 89-94. Go to original source... Go to PubMed...
  5. Sudoh, T. et al. A new natriuretic peptide in porcine brain. Nature, 1988, 332, p. 78-81. Go to original source... Go to PubMed...
  6. Kazda, A. et al. Akutní onemocnění mozku - poruchy vodního a natriového hospodářství, natriuretické peptidy. Klin. Biochem. Metab., 2003, 11, s. 74-82.
  7. Strohle, A. et al. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder. Am. J. Psychiatry, 2001, 158, p. 1514-1516. Go to original source... Go to PubMed...
  8. Hobbs, F. D. et al. The diagnosis of heart failure in European primary care: The Improvement Programme survey of perception and practice. Eur. J. Heart Fail., 2005, 7, p. 768-779. Go to original source... Go to PubMed...
  9. Kirk, V. et al. N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). Eur. J. Heart. Fail., 2004, 6, p. 335-341. Go to original source... Go to PubMed...
  10. Wijdicks, E. F. et al. Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage. Stroke, 1991, 22, p. 1519-1524. Go to original source... Go to PubMed...
  11. Berendes, E. et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet, 1997, 349, p. 245-249. Go to original source... Go to PubMed...
  12. Sviri, G. E. et al. Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage: Clinical and TCD correlations. Stroke, 2000, 31, p. 118-122. Go to original source... Go to PubMed...
  13. McGirt, M. J. et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery, 2004, 54, p. 1369-1373. Go to original source... Go to PubMed...
  14. Sviri, G. E. et al. Alteration in brain natriuretic peptide (BNP) plasma concentration following severe traumatic brain injury. Acta Neurochir., 2006, 148, p. 529-533. Go to original source... Go to PubMed...
  15. Jensen, J. K. et al. N-terminal pro-brain natriuretic peptide after acute ischemic stroke. Cerebrovasc. Dis., 2006, 22, p. 439-444. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.